The pharmaceutical giant presented mid-stage trial data on the pill, muvalaplin, at the American Heart Association Scientific ...

Dexcom and ŌURA have partnered to integrate Dexcom's glucose biosensing feature with the ŌURA Ring's health metrics to help ...

DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, and ŌURA, maker of the world’s leading smart ring, ...

URA, which is now valued at more than $5bn, is set to integrate Dexcom’s glucose capabilities with the Oura ring.

Smart ring maker Oura and glucose monitoring giant Dexcom just struck a partnership that will allow the company's products to ...

Oura recently introduced its fourth-generation smart ring, but now it’s focusing on a new partnership with another giant in ...

Dexcom (Nasdaq:DXCM) announced today that it entered into a strategic partnership with Oura, maker of leading smart ring ...

Smart ring maker Oura announced on Tuesday that it has received a $75 million investment from glucose device maker Dexcom.

Dexcom has invested $75 million into Oura, which values Oura at $5 billion. And the details of the deal could have a ...

Smart ring company Oura announced it received $75 million in funding from glucose monitoring and diagnostics company Dexcom.

DexCom invests $75M in Finnish health tech firm ŌURA, forming a strategic partnership to integrate glucose data with vital signs and biometrics.

URA has just announced a partnership with Dexcom that will allow the Oura Ring to help monitor your blood sugar.